KLRC1 and viral infectious disease: In the context of viral infections such as HIV, elevated levels of HLA-E/NKG2A interactions have been shown to reduce HIV-infected target cell clearance by NK cells48, suggesting that blocking the interaction will unleash NK cell killing and emphasizing a role for this in novel therapeutics.